Idaho Society of Health-System Pharmacists

September 23 , 24 & 25, 2016

Sun Val ley Inn

Sun Va l l ey , Idaho

"The Future of Pharmacy Practice: Provider Status and Collaborative Practice"

2016 ISHP ANNUAL FALL CONFERENCE

1 WELCOME

from the

2015-2016 ISHP Board of Directors

President: Chris Oswald President Elect: Lindsay Kaster Secretary/Treasurer: Dawn Berheim Past President: Debbie Rothstein Administrative Affairs: Scott Milner Education: Brandon Griffith Programs: Eliza Borzadek Legal & Public Affairs: John Sullivan Professional Affairs: Andrea Winterswyk Website Chair: Jim Nguyen Newsletter Editor: Kent Quickstad Technician Rep.: Leann Bolster ASHP Liaison: Beverly Black / Kimberly Berry North Idaho Rep.: Steve Crenshaw Central Idaho Rep.: Elizabeth Duncan ISU Representative: Rebecca Hoover ASHP Delegate: Mike Dickens ASHP Delegate: Elizabeth Duncan ISU Student Rep.: Serena Hand (Pocatello) ISU Student Rep.: Monica McLain (Meridian)

The Idaho Society of Health- System Pharmacists (ISHP) is so pleased that you can join us as we celebrate 60 years of service to the pharmacy industry in the State of Idaho, and our region. We wish to thank our many Boards of Directors, both past and present, for leading us to this occasion. Most importantly, we want to thank you, our members,

for six decades of support and service to your pharmacy team colleagues as we work to build and advance the practice of pharmacy for future generations.

HAPPY 60TH ANNIVERSARY ISHP! We look forward to celebrating the contributions and growth

of this organization in another six decades!

2

ISHP PAST PRESIDENTS (Fall 2015 - Pictured from right to left):

Chris Oswald, Leo Nickasch, Rob Wills, Angela Melbihess, Mike Dickens, Debbie Rothstein, Kent Quickstad, Paul Driver and Jim Jurgens

"THE FUTURE OF PHARMACY PRACTICE: PROVIDER STATUS AND COLLABORATIVE PRACTICE"

The purpose of this live continuing pharmacy education program is to provide a variety of topics to properly educate pharmacists and pharmacy technicians with new and updated information, methodologies and advancing pharmacy techniques. This continuing education program includes the following topics: Telehealth, BioSimilar Updates, Provider Status and a UPS 797 Review. The pharmacy team will also get updates on Diabetes Mellitus, New Drug Updates, Oral Chemotherapy, Sterile Compounding, Breast Cancer and Ocular Disease, as well as a full Idaho Law Update. The presentations will continue by including development presentations in Clinical Pearls, Layered Learning Model and Pharmacy Promotion and Development. Two workshops on infectious diseases (immunizations) as well as professional development for pharmacy technicians are included. Finally, a law class will also be offered during the Proceedings.

TARGET AUDIENCE The "The Future of Pharmacy Practice: Provider Status and Collaborative Practice" Program is a Knowledge and Application-based CPE program. Each activity will include assessment questions structured to determine the recall of facts or applications of information learned. This program is designed and accredited specifically for pharmacists and pharmacy technicians who practice in a variety of settings.

CONTINUING EDUCATION CREDITS

The Idaho Society of Health-System Pharmacists (ISHP)is a fully accredited provider of continuing pharmacy Education by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Participants attending all sessions and completing a program evaluation may be awarded 13.5 contact hours (1.35 CEUs) upon registration, attendance and completion of all required pre-tests, post-tests and evaluations that are available via the ishp.learningexpressce.com continuing education system. To properly claim ACPE credit, one must attend the ACPE accredited activity, in its entirety, and complete the post-test and evaluations that are provided online through Learning ExpressCE. In accordance with the National Association of Boards of Pharmacy (NABP) pharmacy credit reporting program, participants will have 60 days after the completion of the program to submit an evaluation for the activity. To claim credit and to help us assess your future educational needs, you must complete the evaluation process by November 23rd, 2016. After November 23, 2016, you will not be able to submit an evaluation or gain credit for the program. After you have completed your evaluations, the ISHP Learning Express CE system will process your credits with CPE Monitor / NABP automatically.

ISHP members receive a discount on conference registration fees. Pharmacists and Pharmacy Technicians, in all practice settings, are welcomed to become a member of the ISHP. Other health care professionals or

supportive industry partners may also join as associate members.

We offer special member rates for students, residents, retired pharmacists, and technicians. To become a member of the ISHP visit ishp.shuttlepod.org.

LOCATION & ACCOMMODATIONS

The ISHP Annual Fall Meeting is being held at the Sun Valley Inn at the Sun Valley Resort and Conference Center, Sun Valley Idaho. For hotel reservations, contact Sun Valley Resort at 1-800-786-8259 and ask for the special ISHP Annual Fall Meeting room Block or register online by clicking here. REGISTRATION

Meeting registration includes educational sessions and materials, access to exhibits, breaks, receptions, continental breakfast and lunch. All registrants wishing to gain credit for the sessions must register online at ishp.learningexpressce.com. Payment can be made on the Learning ExpressCE website or by registering online and mailing in payment to the ISHP office.

CANCELLATION POLICY

A full refund of registration fees will be made if ISHP cancels the program. Except in cases of emergency, no refund requests will be considered after SEPTEMBER 18th. All requests for refunds must be made in writing to the ISHP. Refunds will be processed following the meeting proceedings.

PHOTO DISCLOSURE

The ISHP reserves the right to use any photograph/video taken at this event, without the expressed written permission of those included within the photograph/video. The ISHP may use the photos/videos in publications or other media material produced, used or contracted by ISHP. A person attending an ISHP event who does not wish to have their image recorded for distribution should make their wishes known to the ISHP staff via email at ishpcontact@gmail.com or at the event itself.

3

PHARMACIST SCHEDULE AT A GLANCE FRIDAY, SEPTEMBER 23 RD 10:00am-12:45 pm ISHP Board Meet ing

Noon Reg ist rat ion Opens

12:55-1:00 pm Welcome & Introduct ion Chr is Oswald, ISHP Pres ident 1:00-2:00 pm Telehealth: Innovat ive Ways to Expand Access to C l in ica l Care Specia l ty Pharmacists Kat ie Er ickson, PharmD, BCPS, BCACP Room: Cont inental Room 2:00-3:00 pm Bios imi lars: Now and Into the Future John P i lon, PhD Room: Cont inental Room 3:00-3:30 pm Afternoon Break & Exh ib i tors Room: Exhibi t Hal l—Limel ight A&B 3:30-4:30 pm <797>: A Pharmacy Odyssey Gretchen B lef fer t , RPh Room: Cont inental Room 4:30-7:00 pm ISHP Welcome Recept ion Inc lud ing Poster Presentat ion and Judging IPREF “Lucky Duck” Event Room: Exhibi t Hal l—Limel ight A&B

SATURDAY, SEPTEMBER 24 TH 7:00-7:50 am Registrat ion Cont inenta l Breakfast Room: Exhibi t Hal l—Limel ight A&B 7:50-8:00 am Welcome & Introduct ion Chr is Oswald, ISHP Pres ident 8:00-9:00 am Provider Status: The Road Behind and the Path Ahead Chr is topher Topolesk i , ASHP Director , Federa l Leg is lat ive Af fa i rs Room: Cont inental Room 9:00am-10:00 am PGY2 Cl in ica l Pear ls VA Resident Team:

Andrea Winterswyk, PharmD L indsey Hunt , PharmD L indsay Crawford, PharmD Jef ferson Bohan, PharmD, BCPS Joe Berendse, PharmD Room: Cont inental Room

10:00am-10:30 am Morn ing Coffee & Dr ink Break, Exhib i tor Spot l ight and F ina l i zat ion o f Poster Compet i t ion Judging Room: Exhibi t Hal l—Limel ight A&B

4 SATURDAY, SEPTEMBER 24 TH (CONT. ) 10:30am-11:30 am P1-P4 Residency Forum Residents & Res idency Directors Room: Aspen Room 10:30am-11:30 am Promotion of the Profess ion & Nat ional Pharmacy Recruitment Jenni fer Adams, PharmD Room: Cont inental Room 11:30am-12:30 pm ISHP Member Bus iness Lunch Room: Limel ight C ISHP Student and Res ident Lunch Room: Ram Room 12:30 pm-1:00 pm Member Awards and Poster Compet i t ion Resul ts Room: Limel ight C 1:00 pm-2:30 pm New and Upcoming Therapies for Diabetes Mel l i tus Cara L iday, PharmD, CDE Room: Cont inental Room 2:30 pm-3:00 pm Afternoon Break & Exh ib i tor Spot l ight Room: Exhibi t Hal l—Limel ight A&B 3:00 pm-6:00 pm Infect ious Disease / Ant ib iot ic Workshop—L imel ight C Sarah McCla in, PharmD, BCPS Derek Gunter , PharmD Char les Jensen, PharmD, BCPS Jef ferson Bohan, PharmD, BCPS Room: Limel ight C

SUNDAY, SEPTEMBER 25 TH 7:00-7:50 am Registrat ion Cont inenta l Breakfast Room: Exhib i t Hal l—Limel ight A & B 7:50-8:00 am Welcome & Introduct ion L indsay Kaster , ISHP Pres ident 8:00-9:00 am Rise Up! Maximiz ing the Layered Learning Model to Improve Pat ient Outcomes Rob Wi l l s , PharmD, BCPS Room: Cont inental Room 9:00-10:00 am Oral Chemotherapy A lanna Causebrook, PharmD and Anna Howard, PharmD Room: Cont inental Room 10:00-10:30 am Morn ing Break & Exh ib i tor Spot l ight Room: Exhib i t Hal l—Limel ight A & B 10:30-11:30 am Idaho Pharmacy Law: Pract ica l Appl icat ions A lex Adams, PharmD—Execut ive Director , Idaho Board of Pharmacy Room: Cont inental Room

PHARMACIST PROGRAM / SCHEDULE

5 FRIDAY, SEPTEMBER 25TH (CONT. ) After participating in this knowledge-based continuing pharmacy education activity, participants should be able to:

1. Review and Describe the current use of biologics; 2. Understand and explain the key differences between

biologics and small molecule pharmaceuticals; 3. Describe the key definitions in biosimilar drug

development; 4. Understand and describe the US—FDA biosimilar approval

pathway/process; 5 . Analyze and be able to explain the potential impact of

biosimilar approvals in the US. 3:00-3:30 pm Afternoon Break & Exh ib i tors Exhib i t Ha l l—Limel ight B 3:30-4:30 pm <797>: A Pharmacy Odyssey ( O n e C o n t a c t H o u r ) Gretchen B lef fer t , RPh ACPE# 0173-0000-16-023-L04-P This presentation will provide an overview of sterile compounding best practices with a specific focus on USP 797. This comprehensive seminar will examine the vital role of 797 and the need for proper aseptic techniques as a proper compounding practice. Moreover, the presentation will include a full review of the pending changes to USP 797, which have been released for public comment. This speaker declares no relationships that holds the potential for bias or commercial conflict in this presentation. After participating in this knowledge-based continuing pharmacy education activity, participants should be able to: 1. Recall and identify the basic organization of USP General

Chapter <797>. 2. Identify and explain the practical changes to environmental

quality and control processes that result in greater compliance with USP General Chapter <797>.

3. Describe proposed updates to USP General Chapter <797>. 4:30-7:00 pm ISHP Welcome Recept ion Inc lud ing Poster Presentat ion and Judg ing IPREF “Ducks on a Pond” Event SATURDAY, SEPTEMBER 24 TH 7:00-7:50 am Registrat ion Cont inenta l Breakfast Exhib i t Ha l l—Limel ight B 7:50-8:00 am Welcome & Introduct ion Chr is Oswald, ISHP Pres ident

FRIDAY, SEPTEMBER 23 RD 10:00 am-12:45 pm ISHP Board Meet ing Noon Regis t rat ion Opens 12:55-1:00 pm Welcome & Introduct ion Chr is Oswald, ISHP Pres ident 1:00-2:00 pm Telehealth: Innovat ive Ways to Expand Access to C l in ica l Care Specia l ty Pharmacists ( O n e C o n t a c t H o u r ) Kat ie Er ickson, PharmD, BCPS, BCACP ACPE# 0173-0000-16-021-L04-P This educational presentation will address the current and future opportunities that exist for improved patient outcomes by utilizing two way, real-time interactive communication between the patient and the practitioner, from a distance, by means of virtual, interactive telecommunications equipment. The presenter will discuss the pros and cons of implementing this type of service, as well as, the hurdles and pitfalls that may exist in achieving full implementation. This speaker declares no relationships that holds the potential for bias or commercial conflict in this presentation. After participating in this knowledge-based continuing pharmacy education activity, participants should be able to:

1. Define Clinical Video Telehealth (CVT); 2. Describe the two main functions of a primary care clinical

pharmacy specialist (CPS) within a telehealth team; 3. Identify and describe the barriers and solutions to

implementation of telehealth CPS services; 4. Recognize and explain the benefits of CVT and CPS services. 2:00-3:00 pm Bios imi lars: Now and Into the Future ( O n e C o n t a c t H o u r ) John P i lon, PhD ACPE# 0173-0000-16-040-L01-P This educational presentation will address the current use and development of biosimilar pharmaceuticals. The presentation will discuss the cost differential between biosimilars and general pharmaceuticals. Moreover, it will discuss the FDA’s process for approving biologics and where some of those complex molecules stand in the approval process, within the FDA and other foreign approving agencies. The speaker will discuss the differences between of biologics and similar pharmaceuticals both in testing and in makeup. This speaker declares no relationships that holds the potential for bias or commercial conflict in this presentation.

SATURDAY, SEPTEMBER 24 TH (CONT. ) 8:00-9:00 am Provider Status: The Road Behind and the Path Ahead ( O n e C o n t a c t H o u r ) Chr is topher Topolesk i , ASHP Di r . , Federa l Leg is lat ive Af fa i rs ACPE# 0173-0000-16-024-L03-P As the theme of the 2016 ISHP Annual Fall Meeting suggests, pharmacists are on the eve of being fully recognized and reimbursed as health care providers. Moreover, pharmacists are being viewed as key team members in the development of patient-focused, collaborative health care practices. This educational presentation will provide detailed information on the legal landscape that would establish pharmacists as “providers,” on a state and federal basis, as well as, to discuss the legislative changes that are currently being considered that would establish this status. The presentation will focus on the role each state plays as well as the role of the federal government plays in determining what services pharmacists can offer to their patients. This speaker declares no relationships that hold the potential for bias or commercial conflict in this presentation. After participating in this knowledge-based continuing pharmacy education activity, participants should be able to: 1. Describe what is meant by provider status in the Medicare

program as defined in the Social Security Act and distinguish it from provider status at the state level.

2. Describe H.R. 592/S. 314 and its intent, as well as gain an understanding of how the bill has evolved and what steps lie ahead in Congress and beyond.

3. Understand and explain the Patient Access to Pharmacists Care Coalition and who comprises it.

4. Recognize and advocate for pharmacists as providers in federal law and how to engage the Idaho State Board of Pharmacy.

9:00 -10:00 am PGY2 Cl in ica l Pear ls ( O n e C o n t a c t H o u r ) VA Resident Team: Andrea Winterswyk, PharmD L indsey Hunt , PharmD L indsay Crawford, PharmD Jef ferson Bohan, PharmD, BCPS Joe Berendse, PharmD ACPE# 0173-0000-16-022-L04-P The Clinical Pearls session will provide attendees with a detailed review of several clinical cases when key pharmacy practices and learning opportunities have come into play. The presenting team will review each case and provide a detailed account of the treatment process, and key elements that impacted the treatment of the patient or would have improved patient outcomes in each instance. These speakers declare no relationships that holds the potential for bias or commercial conflict in this presentation.

6 PHARMACIST PROGRAM / SCHEDULE

SATURDAY, SEPTEMBER 24 TH (CONT. ) After participating in this knowledge-based continuing pharmacy education activity, participants should be able to:

1. Explain the association between readmission rates and diuretic prescribing upon discharge in hospitalized patients with acute decompensated heart failure

2. Understand and describe the risk factors for multi-drug resistant organisms including methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in patients with community-onset pneumonia and the appropriate treatment of those patients in the absence of HCAP.

3. Identify medications for T2DM that may reduce risk of macrovascular complications.

4. Describe potential alternative therapeutic options for management of treatment-resistant generalized anxiety disorder.

5. Identify approaches to resolve calcium channel blocker induced peripheral edema.

10:00-10:30 am Morning Coffee & Dr ink Break Exhib i tor Spot l ight & F inal izat ion of Poster Compet i t ion Judging Exhib i t Hal l—Limel ight A & B 10:30-11:30 am P1-P4 Residency Forum ( O n e C o n t a c t H o u r ) Res idents & Residency D i rectors Aspen Room 10:30-11:30 am Promotion of the Profess ion & Nat ional Pharmacy Recruitment ( O n e C o n t a c t H o u r ) Jenn i fer Adams, PharmD ACPE# 0173-0000-16-025-L01-P This presentation will address a variety of topics regarding the recruitment, development and growth of the current number of pharmacists in the United States. The AACP representative will discuss the current recruitment efforts and development tactics in its work to grow and develop the practice of pharmacy in the US market. The presentation will discuss current statistics and trends from the pharmacy industry as well as where growth may occur in the future. This speaker declares no relationships that holds the potential for bias or commercial conflict in this presentation. After participating in this knowledge-based continuing pharmacy education activity, participants should be able to: 1. Describe the role of the Pharmacy Career Information

Council and current pharmacy recruitment activities. 2. Describe the current PharmD applicant environment. 3 . Discuss opportunities for state boards and associations to

collaborate with schools and colleges of pharmacy on recruitment activities.

PHARMACIST PROGRAM / SCHEDULE 7

bolster their antimicrobial practice, while also building a stewardship tool kit, which can be shared with their respective institutions. These speakers nor the moderator declare a relationships that hold the potential for bias or commercial conflict within this presentation.

After participating in this knowledge-based continuing pharmacy education activity, participants should be able to:

1. Differentiate asymptomatic bacteriuria from a urinary tract infection based on patient signs and symptoms.

2. Apply treatment criteria and provide treatment options for asymptomatic bacteriuria and urinary tract infections to a patient case.

3. Differentiate asymptomatic bacteriuria from a urinary tract infection based on patient signs and symptoms.

4. Compare and contrast the risk factors for multi-drug resistant pathogens in hospital-acquired and ventilator-associated pneumonias (HAPS, VAPs).

5. Describe the common stewardship interventions that can improve the care of patients with HAPs or VAPs.

SUNDAY, SEPTEMBER 25 TH 7:00-7:50 am Registrat ion Cont inenta l Breakfast Exhib i t Hal l—Limel ight A & B 7:50-8:00 am Welcome & Introduct ion L indsay Kaster , ISHP Pres ident 8:00-9:00 am Rise Up! Maximiz ing the Layered Learning Model to Improve Pat ient Outcomes Rob Wi l ls , PharmD, BCPS ACPE# 0173-0000-16-028-L04-P

This educational presentation will fully discuss the integration of the pharmacy team, including the growing use of technicians, residents and pharmacy students in order to properly focus on improved outcomes and patient centered care. The discussion will focus on different models and the utilization of real-world examples in order to showcase how the tasks that are currently performed by pharmacists can be can be diverted toward technicians and other pharmacy team members, which will allow pharmacist to focus on critical patient care management. This speaker declares no relationships that holds the potential for bias or commercial conflict in this presentation.

After participating in this knowledge-based continuing pharmacy education activity, participants should be able to:

1. Describe some effective ways to include residents and students into your institution.

2. Review and discuss the most common pharmacy practice models as identified by the ASHP Pharmacy Practice Model Initiative.

3. Define methods for identifying opportunities for seamless integration of pharmacy residents and pharmacy students into your practice model.

4. Understand the Layered Learning Model and how to use it to expand pharmacy services.

5. Understand the benefits and outcomes of the layered learning model using pharmacy students as pharmacist extenders.

6. Identify areas of practice that can be expanded or added as a result of using a layered learning model.

SATURDAY, SEPTEMBER 24 TH (CONT. ) 11:30am-12:30 pm ISHP Member Business Lunch L imel ight C ISHP Student/Resident Lunch Ram Room 12:30—1:00 pm Member Awards and Poster Compet i t ion Results L imel ight C 1 :00-2:30 pm New and Upcoming Therapies for Diabetes Mel l i tus ( O n e a n d H a l f C o n t a c t H o u r s ) Cara L iday, PharmD, CDE ACPE# 0173-0000-16-026-L01-P

This educational presentation will address the advancing pharmacological therapies for Diabetes Mellitus. In addition, the discussion will review specific cases and the differing types of insulin treatments that could be utilized to improve patient outcomes. The presenter will discuss the background of the glycemic control algorithm as well as the history and ever changing state of insulin. Finally, the presentation will review multiple new treatment options and patient education that must accompany each of the advancing treatment options. This speaker declares no relationships that holds the potential for bias or commercial conflict in this presentation.

After participating in this knowledge-based continuing pharmacy education activity, participants should be able to: 1. Describe new and emerging therapies for the treatment of

diabetes mellitus. 2. List the potential pros and cons of new and emerging

therapies. 3. Discuss the potential implications of these therapies on

clinical practice. 4. Describe important dispensing and counseling points for each

new class of medication. 2:30 pm-3:00 pm Af ternoon Break & Exh ib i tor Spot l ight Exhib i t Hal l—Limel ight A & B 3 :00-6:00 pm Infect ious Disease / Ant ib iot ic Workshop ( T h r e e C o n t a c t H o u r s ) L imel ight C Sarah McCla in, PharmD, BCPS Derek Gunter , PharmD Char les Jensen, PharmD, BCPS Jef ferson Bohan, PharmD, BCPS ACPE# 0173-0000-16-022-L04-P

The Infectious Disease Roundtable Workshop will focus on the implementation of various infectious disease and antimicrobial stewardship programs in the region. Attendees will have an opportunity to discuss and review the current antimicrobial programs within the various pharmacy settings in our area as well as review best practices and learn about areas they can where they may be able to improve their programs. The attendees will have the opportunity to gain information that will allow them to

PHARMACIST PROGRAM / SCHEDULE

J o i n t h e I d a h o P h a r m a c y R e s e a r c h a n d E d u c a t i o n F o u n d a t i o n ( I P R E F ) f o r a n

e v e n i n g o f f o o d , f u n a n d f r i e n d s , w h i l e w e s u p p o r t a g r e a t c a u s e !

How “Lucky” of a duck wrangler are you?

U t i l i z e y o u r d u c k w r a n g l i n g s k i l l s a n d t a k e h o m e s o m e e x c e p t i o n a l p r i z e s , i n c l u d i n g A m a z o n F i r e s t i c k s , A p p l e

T V , g r e a t w i n e e x p e r i e n c e s a n d a t o n o f o t h e r p r i z e s .

E v e r y D u c k W i n s a P r i z e !

A L L p r o c e e d s s u p p o r t I P R E F , w h i c h s u p p o r t s s t u d e n t s c h o l a r s h i p s , t r a v e l t o c l i n i c a l c o m p e t i t i o n s , m e m b e r

r e s e a r c h p r o j e c t s a n d M O R E !

FOR EXHIBITOR INFORMATION PLEASE CHECK OUT www.ishp.shuttlepod.org

ISHP P.O. Box 7625 Boise, Idaho 83707 Phone: 208.342.2581 Fax: 888.959.0140 Email: ishpcontact@gmail.com

Thank you to our ISHP Fall Conference Committee

Chairs: Brandon Griffith and Eliza Borzadek 

Chris Oswald Erin Kohler Catherine Gundlach Amber Fisher Arielle Martin Rob Wills John Sullivan Josh Ingram Karl Clough Scott Downey Robert Mancini Jessie Litke

Kendall Crane Randi Griffiths Brittin Hutchison Robert Moore

8 10:30-11:30 am Idaho Pharmacy Law: Pract ica l Appl icat ions A lex Adams, PharmD— Execut ive Director , Idaho Board of Pharmacy ACPE# 0173-0000-16-029-L03-P

This presentation will discuss current changes to Idaho Pharmacy Law and administrative rules that were enacted or were discussed during the 2016 Idaho Legislative Session, as well as proposed bills and pending rule promulgation that the Idaho Board of Pharmacy intends to bring before the 2017 Idaho Legislature. In addition, the speaker will discuss the active role that pharmacists can play in their roles as providers, which currently adheres to Idaho law. This speaker declares no relationships that holds the potential for bias or commercial conflict in this presentation. After participating in this knowledge-based continuing pharmacy education activity, participants should be able to:

1. Describe changes to Idaho Pharmacy Law that took effect in 2016.

2. Discuss changes to Idaho Pharmacy that the board has positioned for 2017.

3. Describe recent board changes and implications for pharmacists and technicians.

SUNDAY, SEPTEMBER 25 TH (CONT. ) 9 :00-10:00 am Oral Chemotherapy A lanna Causebrook, PharmD and Anna Howard, PharmD ACPE# 0173-0000-16-022-L04-P This educational presentation will delve into the increasing use of oral formulations of chemotherapy drugs for cancer treatments, which offers a more convenient and less invasive treatment option for patients. The presentation will provide a full review of the most common oral chemotherapy agents available, including potential adverse reactions and drug interactions. Moreover, there will be some review of the financial differentials of the differing types of chemotherapy pharmaceuticals. The discussions will include the necessary drug counseling and patient discussions that go along with the different types of chemotherapy drugs. These speakers declares no relationships that holds the potential for bias or commercial conflict in this presentation. After participating in this knowledge-based continuing pharmacy education activity, participants should be able to: 1. Evaluate the use and placement of therapy of oral

chemotherapy agents; 2. List new oral chemotherapy agents; 3. Understand important counseling information for new oral

chemotherapy agents; 4. Recognize key adverse drug reactions and management. 10:00-10:30 am Morn ing Break & Exh ib i tor Spot l ight Exhib i t Hal l—Limel ight A & B

PHARMACY TECHNICIAN SCHEDULE AT A GLANCE FRIDAY, SEPTEMBER 23 RD

10:00am-12:45 pm ISHP Board Meet ing Noon Reg ist rat ion Opens 12:55-1:00 pm Welcome & Introduct ion LeAnn Bolster , ISHP Technic ian Representat ive Room: Columbine Room 1:00-2:00 pm Psychiatr ic Diseases and Treatment She lby White , PharmD Megan Turner, PharmD Room: Columbine Room 2:00-3:00 pm Immunizat ions / Vacc inat ions N ico le Lopez, PharmD James Lufk in, PharmD Room: Columbine Room 3:00-3:30 pm Afternoon Break & Exh ib i tors Room: Exhibi t Hal l—Limel ight A&B 3:30-4:30 pm <797>: A Pharmacy Odyssey Gretchen B lef fer t , RPh Room: Cont inental Room 4:30-7:00 pm ISHP Welcome Recept ion Inc lud ing Poster Presentat ion and Judging IPREF “Lucky Duck” Event Room: Exhibi t Hal l—Limel ight A&B SATURDAY, SEPTEMBER 24 TH 7:00-7:50 am Registrat ion Cont inenta l Breakfast Room: Exhibi t Hal l—Limel ight A&B 7:50-8:00 am Welcome & Introduct ion LeAnn Bolster , ISHP Technic ian Representat ive 8:00-9:00 am Dosage Calculat ions Jordan Ferro, PharmD Brett Hea ly , PharmD, MS Room: Columbine Room 9:00am-10:00 am Medicat ion Reconci l iat ion Kr is Lark, PharmD, MS Matthew Wright, PharmD Room: Columbine Room 10:00am-10:30 am Morn ing Coffee & Dr ink Break, Exhib i tor Spot l ight and F ina l i zat ion o f Poster Compet i t ion Judg ing Room: Exhibi t Hal l—Limel ight A&B

9 SATURDAY, SEPTEMBER 24 TH (CONT. ) 10:30am-11:30 am Breast Cancer: C lass i f icat ion and Treatment A lanna Causebrook, PharmD Anna Howard, PharmD Room: Columbine Room 11:30am-12:30 pm ISHP Member Bus iness Lunch Room: Limel ight C ISHP Student and Res ident Lunch Room: Ram Room 12:30 pm-1:00 pm Member Awards and Poster Compet i t ion Resul ts Room: Limel ight C 1:00 pm-2:30 pm Toxidromes: C l in ica l Presentat ion and Treatment Brooke Benson, PharmD Miche la A l tergott , PharmD A lex is Zastoup i l , PharmD Room: Columbine Room 2:30 pm-3:00 pm Afternoon Break & Exh ib i tor Spot l ight Room: Exhibi t Hal l—Limel ight A&B 3:00 pm-6:00 pm Profess ional Development Workshop Megan Koyle, PharmD, BCPS LeAnn Bolster , CPT Room: Columbine Room SUNDAY, SEPTEMBER 25 TH 7:00-7:50 am Registrat ion Cont inenta l Breakfast Room: Exhibi t Hal l—Limel ight A&B 7:50-8:00 am Welcome & Introduct ion LeAnn Bolster , ISHP Technic ian Representat ive 8:00-9:00 am Parentera l Nutr i t ion Miche l le Wi lk in, PharmD Matthew McC lure, PharmD Room: Columbine Room 9:00-10:00 am An Eye Catching Review of Ocular Disorders and Treatment Nam Nguyen, PharmD Brent Sasak i , PharmD Room: Columbine Room 10:00-10:30 am Morn ing Break & Exh ib i tor Spot l ight Room: Exhibi t Hal l—Limel ight A&B 10:30-11:30 am Idaho Pharmacy Law: Pract ica l Appl icat ions A lex Adams, PharmD—Execut ive Director , Idaho Board of Pharmacy Room: Cont inental Room

10 PHARMACY TECHNICIAN PROGRAM / SCHEDULE

FRIDAY, SEPTEMBER 25TH (CONT. ) 3:00-3:30 pm Afternoon Break & Exh ib i tors Exhib i t Ha l l—Limel ight B 3 :30-4:30 pm <797>: A Pharmacy Odyssey ( O n e C o n t a c t H o u r ) Gretchen B lef fer t , RPh ACPE# 0173-0000-16-023-L04-T This presentation will provide an overview of sterile compounding best practices with a specific focus on USP 797. This comprehensive seminar will examine the vital role of 797 and the need for proper aseptic techniques as a proper compounding practice. Moreover, the presentation will include a full review of the pending changes to USP 797, which have been released for public comment. This speaker declares no relationships that holds the potential for bias or commercial conflict in this presentation.

After participating in this knowledge-based continuing pharmacy education activity, participants should be able to:

1. Recall and identify the basic organization of USP General Chapter <797>.

2. Identify and explain the practical changes to environmental quality and control processes that result in greater compliance with USP General Chapter <797>.

3. Describe proposed updates to USP General Chapter <797>.

4:30-7:00 pm ISHP Welcome Recept ion Inc lud ing Poster Presentat ion and Judging IPREF “Ducks on a Pond” Event SATURDAY, SEPTEMBER 24 TH 7 :00-7:50 am Registrat ion Cont inenta l Breakfast Exhib i t Hal l—Limel ight B 7:50-8:00 am Welcome & Introduct ion LeAnn Bols ter , ISHP Technic ian Representat ive 8:00-9:00 am Dosage Calculat ions ( O n e C o n t a c t H o u r ) Jordan Ferro, PharmD Bret t Healy , PharmD, MS ACPE# 017 3-0000-16 -03 2-L04 - T This educational presentation will provide an overview and practical applications to expand comprehension of simple to complex dosage calculations as well as to provide calculation exercises that will assist attendees in performing accurate and safe dosage calculations. Dimensional analysis and flow rates will be fully discussed in order to ensure practice of medication concentration and desired dosages. These speakers declare no relationships that hold the potential for bias or commercial conflict in this presentation.

FRIDAY, SEPTEMBER 23 RD 10:00am-12:45 pm ISHP Board Meet ing Noon Reg ist rat ion Opens 12:55-1:00 pm Welcome & Introduct ion LeAnn Bolster , ISHP Technic ian Representat ive 1:00-2:00 pm Psychiatr ic Diseases and Treatment ( O n e C o n t a c t H o u r ) She lby Whi te, PharmD Megan Turner , PharmD ACPE# 0173-0000-16-030-L01-T This educational presentation will address the five basic psychiatric disorders as well as the general pharmacological treatments for each of the identified disorders. In addition to the pharmacological treatments, the speakers will review numerous non-pharmacological treatments that could be utilized for the various disorders. The speakers will review the symptoms of those disorders as well as the side effects from the various treatments. These speakers declare no relationships that holds the potential for bias or commercial conflict in this presentation.

After participating in this knowledge-based continuing pharmacy education activity, participants should be able to:

1. Identify four psychiatric disorders; 2. Describe signs and symptoms associated with these disorders; 3. List medications used in the treatment of depression, anxiety,

bipolar disorder, and schizophrenia; 4. Consider ways to apply this knowledge to improve patient

care. 2:00-3:00 pm Immunizat ions / Vacc inat ions ( O n e C o n t a c t H o u r ) N ico le Lopez, PharmD James Lufk in , PharmD ACPE# 0173-0000-16-031-L01-T

This educational presentation will address the current state of vaccinations, as well as, their discovery, development and the history of immunizations. The speakers will discuss the special preparation, storage and handling of vaccines. The speakers will review special populations and side effects that can come from specific vaccinations. The discussions will include details about Idaho’s IRIS network and the logistics of immunization registration. These speakers declare no relationships that holds the potential for bias or commercial conflict in this presentation.

After participating in this knowledge-based continuing pharmacy education activity, participants should be able to:

1. Summarize the discovery, development, and use history of vaccinations and the impact they have had on infectious disease;

2. Discuss general vaccine storage, administration, and adverse reactions as well as where to find critical vaccine information;

3. Identify special populations which may require unique immunization requirements;

4. List requirements for documentation of vaccines administered to patients.

11 PHARMACY TECHNICIAN PROGRAM / SCHEDULE

SATURDAY, SEPTEMBER 24 TH (CONT. ) 11:30am-12:30 pm ISHP Member Business Lunch L imel ight C ISHP Student/Resident Lunch Ram Room 12:30—1:00 pm Member Awards and Poster Compet i t ion Results L imel ight C 1 :00-2:30 pm Toxidromes: C l in ica l Presentat ion and Treatment ( O n e C o n t a c t H o u r ) Brooke Benson, PharmD Miche la A l tergott , PharmD A lex is Zastoup i l , PharmD ACPE# 0173-0000-16-035-L04-T

This presentation will discuss the most common exposures to toxins, as well as the proper treatment of a patient that is experiencing overdose or acute clinical toxidromes. The discussion will include the proper management of a poisoned patient. These speakers declare no relationships that hold the potential for bias or commercial conflict in this presentation.

After participating in this knowledge-based continuing pharmacy education activity, participants should be able to:

1. Recall the most common causes of toxic exposures; 2. Distinguish common clinical toxidromes associated with

acute; 3. Describe the general management of a patient with an

acute overdose; 4. Assess a patient with an acute overdose and develop a

patient care plan according to current evidence; 5. Identify adverse effects & monitoring of a poisoned patient; 6. Identify which toxidromes must be treated with supportive

care alone and do not have an antidote. 2:30-3:00 pm Afternoon Break & Exh ib i tors Exhib i t Hal l—Limel ight B 3 :00-6:00 pm Profess ional Development Workshop ( O n e C o n t a c t H o u r ) Megan Koyle, PharmD, BCPS LeAnn Bolster , CPT ACPE# 0173-0000-16-036-L04-T

This interactive workshop will focus on the differences between a CV and a resume and teach the attendees how to write a professional CV or resume in order to help technicians "stand out from the crowd." Additional topics will include leadership development and interviewing strategies that will benefit professional careers. These speakers declare no relationships that hold the potential for bias or commercial conflict in this presentation. After participating in this knowledge-based continuing pharmacy education activity, participants should be able to:

1. Distinguish the differences between a curriculum vitae and a resume;

2. Learn essential Interviewing strategies ; 3. Discuss pharmacy technician leadership opportunities.

SATURDAY, SEPTEMBER 24 TH (CONT. ) After participating in this knowledge-based continuing pharmacy education activity, participants should be able to:

1. Solve medication dosage calculations using ratios and proportions.

2. Given a percentage strength, calculate the amount of active and/or inactive ingredients required to prepare a prescription.

3. Given a percentage strength, calculate the amount of active and/or inactive ingredients required to prepare a prescription.

4. Calculate flow rates when given a medication concentration and desired dose.

9:00-10:00am Medicat ion Reconci l iat ion ( O n e C o n t a c t H o u r ) Kr is Lark , PharmD, MS Matthew Wr ight , PharmD ACPE# 0173-0000-16-033-L04-T This knowledge based educational presentation will address a variety of topics concerning medication reconciliation. The presentation will discuss the development of the most complete and accurate list of a patient’s medications and comparing the list to those in the patient record or medication order. Moreover, the discussion will include the best manner in which to ask effective questions to be able to conduct a thorough and full medication reconciliation. These speakers declare no relationships that hold the potential for bias or commercial conflict in this presentation.

After participating in this knowledge-based continuing pharmacy education activity, participants should be able to:

1. Explain the importance of medication reconciliation; 2. List the parts of a complete medication reconciliation; 3. Ask effective questions to be able to conduct a thorough

medication reconciliation. 10:00-10:30 am Morn ing Cof fee & Dr ink Break, Exhib i tor Spot l ight and F ina l i zat ion of Poster Compet i t ion Judg ing 10:30-11:30am Breast Cancer: C lass i f icat ion & Treatment ( O n e C o n t a c t H o u r ) A lanna Causebrook, PharmD Anna Howard, PharmD ACPE# 0173-0000-16-034-L01-T

This educational presentation will fully review the current state of breast cancer treatment, including risk factors, classification, diagnosis and treatment options. The discussions will include the various treatment modalities, including the numerous pharmacological options and potential adverse effects. These speakers declare no relationships that hold the potential for bias or commercial conflict in this presentation.

After participating in this knowledge-based continuing pharmacy education activity, participants should be able to:

1. Review and Describe the current use of biologics ; 2. Describe risk factors for breast cancer; 3. Describe treatment modalities used in breast cancer

biosimilar approvals in the US; 4. Examine and explain the IV admixture requirements for

chemotherapy used in breast cancer .

PHARMACY TECHNICIAN PROGRAM / SCHEDULE SUNDAY, SEPTEMBER 25 TH 7:00-7:50 am Registrat ion Cont inenta l Breakfast Exhib i t Hal l—Limel ight B 7:50-8:00 am Welcome & Introduct ion LeAnn Bolster , ISHP Technic ian Representat ive 8 :00-9:00 am Parenteral Nutr i t ion ( O n e C o n t a c t H o u r ) Miche l le Wi lk in, PharmD Matthew McC lure, PharmD ACPE# 0173-0000-16-037-L01-T

This presentation will address a variety of topics concerning the process of total parenteral nutrition (TPN) as well as both macro and micro-nutrient therapies. The speakers will discuss the difference between enteral and parenteral administration, as well as the safety issues and complications that come along with these types of nutritional administration. These speakers declare no relationships that hold the potential for bias or commercial conflict in this presentation.

After participating in this knowledge-based continuing pharmacy education activity, participants should be able to:

1. Describe the patient that would benefit from TPN. 2. Identify the major macro and micro-nutrient components. 3. Understand the role of the nutrients from a global

perspective. 4. Recognize TPN safety issues and complications. 9:00-10:00 am An Eye Catching Review of Ocular Disorders and Treatment ( O n e C o n t a c t H o u r ) Nam Nguyen, PharmD Brent Sasak i , PharmD ACPE# 0173-0000-16-038-L01-T

This knowledge based presentation will address a variety of topics concerning the anatomy of the eye, as well as, multiple disorders that can impact the eye. The speakers will identify the multiple treatment modalities for the most common ocular disorders, as well as, the processing, handling, dosing and treatment options for rare ocular disease states.

These speakers declare no relationships that hold the potential for bias or commercial conflict in this presentation.

After participating in this knowledge-based continuing pharmacy education activity, participants should be able to:

1. Identify ocular anatomy and define common terms associated with the eye;

2. Recognize the most common disease states associated with the eye ;

3. Briefly describe and identify the available treatment options for the most common ocular disorders;

4. Recognize special dosing, storage, and counseling points for available agents.

12 SUNDAY, SEPTEMBER 25 TH (CONT. ) 10:00-10:30 am Morn ing Break & Exh ib i tor Spot l ight Exhib i t Hal l—Limel ight A&B 10:30-11:30 am Idaho Pharmacy Law: Pract ica l Appl icat ions ( O n e C o n t a c t H o u r ) A lex Adams, PharmD— Execut ive Director , Idaho Board of Pharmacy ACPE# 0173-0000-16-029-L03-T

This presentation will discuss current changes to Idaho Pharmacy Law and administrative rules that were enacted or were discussed during the 2016 Idaho Legislative Session, as well as proposed bills and pending rule promulgation that the Idaho Board of Pharmacy intends to bring before the 2017 Idaho Legislature. In addition, the speaker will discuss the active role that pharmacists can play in their roles as providers, which currently adheres to Idaho law. This speaker declares no relationships that holds the potential for bias or commercial conflict in this presentation.

After participating in this knowledge-based continuing pharmacy education activity, participants should be able to:

1. Describe changes to Idaho Pharmacy Law that took effect in 2016.

2. Discuss changes to Idaho Pharmacy that the board has positioned for 2017.

3. Describe recent board changes and implications for pharmacists and technicians.

ISHP Meeting Registration Fee Schedule

Pharmacist & Resident Technician

FRIDAY ISHP member before 9/9 $ 84.00 $27.00

ISHP member after 9/9 $90.30 $29.03 Non Member before 9/9 $135.00 $45.00 Non Member after 9/9 $145.13 $48.38

SATURDAY ISHP member before 9/9 $ 220.00 $77.50

ISHP member after 9/9 $ 236.50 $83.31 Non Member before 9/9 $ 347.50 $122.50 Non Member after 9/9 $ 373.56 $131.69

SUNDAY ISHP member before 9/9 $ 84.00 $27.00

ISHP member after 9/9 $90.30 $29.03 Non Member before 9/9 $135.00 $45.00 Non Member after 9/9 $145.13 $48.38

All Three Days - “ALLFALL” Codes ISHP member before 9/9 $ 355.00 $119.67

ISHP member after 9/9 $ 381.63 $128.64 Non Member before 9/9 $ 561.93 $193.38 Non Member after 9/9 $ 604.07 $207.88

Idaho Society of Health-System

Pharmacists

2016 ISHP ANNUAL FALL CONFERENCE

Welcome to Welcome to